Now showing items 1-6 of 6

    • A BAFF Receptor His159Tyr Mutation in Sjögren’s Syndrome-Related Lymphoproliferation 

      Papageorgiou A., Mavragani C.P., Nezos A., Zintzaras E., Quartuccio L., De Vita S., Koutsilieris M., Tzioufas A.G., Moutsopoulos H.M., Voulgarelis M. (2015)
      Objective. To study the prevalence, clinical associations, and functional implications of the His159Tyr mutation of the BAFF receptor (BAFF-R) in patients with Sjögren’s syndrome (SS). Methods. The BAFF-R His159Tyr mutation ...
    • BAFF receptor polymorphisms and deficiency in humans 

      Sevdali E., Block Saldana V., Speletas M., Eibel H. (2021)
      The BAFF-receptor (BAFFR) is a member of the TNF-receptor family. It is expressed only by B cells and binds BAFF as single ligand, which activates key signaling pathways regulating essential cellular functions, including ...
    • BAFF/APRIL system is functional in B-cell acute lymphoblastic leukemia in a disease subtype manner 

      Sevdali E., Katsantoni E., Smulski C.R., Moschovi M., Palassopoulou M., Kolokotsa E.N., Argentou N., Giannakoulas N., Adamaki M., Vassilopoulos G., Polychronopoulou S., Germenis A.E., Eibel H., Speletas M. (2019)
      [No abstract available]
    • Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection 

      Xu, H. C.; Huang, J.; Khairnar, V.; Duhan, V.; Pandyra, A. A.; Grusdat, M.; Shinde, P.; McIlwain, D. R.; Maney, S. K.; Gommerman, J.; Löhning, M.; Ohashi, P. S.; Mak, T. W.; Pieper, K.; Sic, H.; Speletas, M.; Eibel, H.; Ware, C. F.; Tumanov, A. V.; Kruglov, A. A.; Nedospasov, S. A.; Häusinger, D.; Recher, M.; Lang, K. S.; Lang, P. A. (2015)
      The B cell-activating factor (BAFF) is critical for B cell development and humoral immunity in mice and humans. While the role of BAFF in B cells has been widely described, its role in innate immunity remains unknown. Using ...
    • Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis 

      Karampitsakos T., Papaioannou O., Dimeas I., Tsiri P., Sotiropoulou V., Tomos I., Papanikolaou I.C., Katsaras M., Kirgou P., Daniil Z., Gourgoulianis K.I., Sampsonas F., Manali E., Papiris S., Bouros D., Tzouvelekis A. (2022)
      [No abstract available]
    • TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis 

      Ntellas P., Dardiotis E., Sevdali E., Siokas V., Aloizou A.-M., Tsinti G., Germenis A.E., Hadjigeorgiou G.M., Eibel H., Speletas M. (2020)
      Recent studies implicate B cells in multiple sclerosis (MS) pathogenesis, and consequently, several molecules participating in B cell survival and proliferation, including B-cell activating factor (BAFF), have recently ...